Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer
Status:
Unknown status
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
Strategies to minimize and mitigate external beam radiation therapy related mucositis and
pain during the treatment of head and neck cancer remain limited. The investigators
hypothesize that gabapentin could be used to delay or reduce treatment-related pain, reliance
on opioid medication, and improve the quality of life for these patients.